InvestSMART

Orthocell Limited (ASX: OCC) - Announcements

Current share price for OCC : $0.550 0.015 (2.80%)+

ASX company news and announcements for Orthocell Limited (OCC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Orthocell Limited (OCC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Orthocell Limited (OCC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Orthocell Limited (OCC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$150 Ceasing to be a substantial holder PA 7 Jun 2019 12:51PM $0.410 $0.550 risen by 34.15%
$150 Change of Director's Interest Notice x 4 7 Jun 2019 12:49PM $0.405 $0.550 risen by 35.80%
$150 Placement Completion 6 Jun 2019 9:48AM $0.405 $0.550 risen by 35.80%
$150 Appendix 3B and Notice Under Section 708A 6 Jun 2019 9:46AM $0.405 $0.550 risen by 35.80%
$150 Appendix 3B and Notice Under Section 708A 31 May 2019 5:58PM $0.455 $0.550 risen by 20.88%
$150 Orthocell announces successful capital raising 30 May 2019 9:46AM $0.465 $0.550 risen by 18.28%
$150 Trading Halt 28 May 2019 9:36AM $0.465 $0.550 risen by 18.28%
$150 Change of Director's Interest Notice * 4 24 May 2019 4:44PM $0.495 $0.550 risen by 11.11%
$150 Appendix 3B and Notice Under Section 708A 21 May 2019 6:46PM $0.505 $0.550 risen by 8.91%
$150 Investor Update 21 May 2019 8:52AM $0.520 $0.550 risen by 5.77%
$150 Results of Meeting 20 May 2019 12:26PM $0.555 $0.550 fallen by 0.90%
$150 Orthocells Recent Success and Opportunities 20 May 2019 11:06AM $0.525 $0.550 risen by 4.76%
$150 Appendix 3B and Notice Under Section 708A 17 May 2019 6:49PM $0.490 $0.550 risen by 12.24%
$150 Change in substantial holding SRV 17 May 2019 6:48PM $0.490 $0.550 risen by 12.24%
$150 Clarification Regarding AustSuper Shareholder Notice 17 May 2019 9:16AM $0.535 $0.550 risen by 2.80%
$150 Change in substantial holding MC 17 May 2019 9:13AM $0.535 $0.550 risen by 2.80%
$150 Change of Director's Interest Notice MC 17 May 2019 9:06AM $0.535 $0.550 risen by 2.80%
$150 Becoming a substantial holder 16 May 2019 4:31PM $0.535 $0.550 risen by 2.80%
$150 Appendix 3B and Notice Under Section 708A 15 May 2019 4:54PM $0.535 $0.550 risen by 2.80%
$150 First Patients Complete Nerve Regeneration Trial 8 May 2019 8:49AM $0.115 $0.550 risen by 378.26%
$150 Orthocell Submits AUS Regulatory Application for CelGro 1 May 2019 9:04AM $0.115 $0.550 risen by 378.26%
$150 Appendix 4C - Quarterly 30 Apr 2019 6:49PM $0.115 $0.550 risen by 378.26%
$150 Notice of General Meeting/Proxy Form 18 Apr 2019 4:37PM $0.130 $0.550 risen by 323.08%
$150 Appendix 3B and Notice Under Section 708A 8 Apr 2019 10:10AM $0.140 $0.550 risen by 292.86%
$150 Orthocells Ortho-ATI Shoulder Tendon Study on Track 6 Mar 2019 8:50AM $0.140 $0.550 risen by 292.86%

526 - 550 of 775 results

Page 22 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.